A. L. Fymat, Nanobiotechnology for treatment of neurological disorders, 23rd International Conference on Pharmaceutical Biotechnology, 2021.
A. L. Fymat, Nanobiotechnology Roles in Brain Cancer Treatment, Invited Keynote Lecture, 6th European Biopharma Congress, New York, New York, USA, 5 April 2021.
A. L. Fymat, Roles of Nanotechnology in the Treatment of Glioblastomas and Neurological Diseases, Second International Conference and Exhibition on Pharmacology and Pharmaceutical Research, Dubai, UAE, April 23-24, 2021.
A. L. Fymat, Nanopharmacology in the Treatment of Neurodegenerative Disorders, International Pharmaceutical Research and Drug Development (GPD 2021) Conference, Prague, Czech Republic, May 14-15, 2021.
A. L. Fymat, Dementia : What do we know about the disease and what can be done about it? International Conference on Dementia, Singapore City, Singapore, June 21-22, 2021.
A. L. Fymat, On Alzheimer's Cure: 19 Important Questions Answered, Invited Keynote at the Fifth International Conference on Neurology & Therapeutics (Neurology 2021), Paris, France, July 7-8, 2021.
A. L. Fymat, Paradigm for pandemic prediction and prevention, presented at the European Union Academy of Sciences Pandemics (e2021 Symposium), Brussels, Belgium, July 15, 2021.
A. L. Fymat, Dementia: Is its root cause a runaway autoimmune disease? Geriatric & Gerontology Conference 2021, October 21-23, 2021, Prague, Czech Republic (converted to virtual).
A. L. Fymat, Glioblastoma surgical and non-surgical treatments: What progress made? Surgery 2021 International Conference & Exhibition on Surgery and Anesthesia, 2-4 December 2021, London, U.K.